Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 2
1992 1
1993 5
1994 1
1997 2
1999 1
2000 1
2001 2
2004 6
2005 3
2006 1
2007 4
2014 1
2015 6
2016 2
2017 5
2018 4
2019 6
2020 5
2021 14
2022 16
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
[Post-acute COVID-19 syndrome].
Szekanecz Z, Vályi-Nagy I. Szekanecz Z, et al. Among authors: valyi nagy i. Orv Hetil. 2021 Jul 4;162(27):1067-1078. doi: 10.1556/650.2021.32282. Orv Hetil. 2021. PMID: 34224394 Review. Hungarian.
COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
Szekanecz Z, Balog A, Constantin T, Czirják L, Géher P, Kovács L, Kumánovics G, Nagy G, Rákóczi É, Szamosi S, Szűcs G, Vályi-Nagy I. Szekanecz Z, et al. Among authors: valyi nagy i. Expert Rev Mol Med. 2022 Mar 15;24:e13. doi: 10.1017/erm.2022.10. Expert Rev Mol Med. 2022. PMID: 35311631 Free PMC article. Review.
Non-Hodgkin lymphoma and hepatitis C: where we are and what next?
Sulyok M, Makara M, Újhelyi E, Vályi-Nagy I. Sulyok M, et al. Among authors: valyi nagy i. Pathol Oncol Res. 2015 Jan;21(1):1-7. doi: 10.1007/s12253-014-9845-z. Epub 2014 Oct 2. Pathol Oncol Res. 2015. PMID: 25273531 Free article. Review.
[Antiviral and anti-inflammatory therapies in COVID-19].
Szekanecz Z, Bogos K, Constantin T, Fülesdi B, Müller V, Rákóczi É, Várkonyi I, Vályi-Nagy I. Szekanecz Z, et al. Among authors: valyi nagy i. Orv Hetil. 2021 Apr 10;162(17):643-651. doi: 10.1556/650.2021.32230. Orv Hetil. 2021. PMID: 33838023 Hungarian.
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups.
Hurler L, Szilágyi Á, Mescia F, Bergamaschi L, Mező B, Sinkovits G, Réti M, Müller V, Iványi Z, Gál J, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Csuka D, Kajdácsi E, Cervenak L, Kiszel P, Masszi T, Vályi-Nagy I, Würzner R; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration; Lyons PA, Toonen EJM, Prohászka Z. Hurler L, et al. Among authors: valyi nagy i. Front Immunol. 2023 Mar 27;14:1162171. doi: 10.3389/fimmu.2023.1162171. eCollection 2023. Front Immunol. 2023. PMID: 37051252 Free PMC article.
Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study.
Szabó BG, Czél E, Nagy I, Korózs D, Petrik B, Marosi B, Gáspár Z, Rajmon M, Di Giovanni M, Vályi-Nagy I, Sinkó J, Lakatos B, Bobek I. Szabó BG, et al. Among authors: valyi nagy i. Antibiotics (Basel). 2023 Jul 17;12(7):1196. doi: 10.3390/antibiotics12071196. Antibiotics (Basel). 2023. PMID: 37508292 Free PMC article.
94 results